| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/03/1998 | US5723323 Method of identifying a stochastically-generated peptide, polypeptide, or protein having ligand binding property and compositions thereof |
| 03/03/1998 | US5723316 α-1-antichymotrypsin analogues having chymase inhibiting activity |
| 03/03/1998 | US5723315 Secreted proteins and polynucleotides encoding them |
| 03/03/1998 | US5723314 Antigens and antibodies and peptides |
| 03/03/1998 | US5723313 ARF-p19, a novel regulator of the mammalian cell cycle |
| 03/03/1998 | US5723310 Aqueous multiple-phase isolation of polypeptide |
| 03/03/1998 | US5723309 Production of subunits of soluble T cell receptors by co-transfection |
| 03/03/1998 | US5723299 Somatostatin receptors |
| 03/03/1998 | US5723129 GnRH-leukotoxin chimeras |
| 03/03/1998 | US5723126 Methods and compositions for therapeutic uses of a fibrin-specific monoclonal antibody |
| 03/03/1998 | US5723125 Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
| 03/03/1998 | US5723120 Method of treating an IL-6 related disease with interleukin-6 receptor antagonists |
| 03/03/1998 | US5723118 Therapeutic agents which are antagonists or partial agonists of human interleukin 4 |
| 03/03/1998 | CA1339694C Human high-affinity neurotranmitter uptake system |
| 02/26/1998 | WO1998007881A1 T1 receptor-like ligand i |
| 02/26/1998 | WO1998007880A1 Human endokine alpha |
| 02/26/1998 | WO1998007877A1 A short-shafted adenoviral fiber and its use |
| 02/26/1998 | WO1998007869A1 HBV POLYMERASE, RNase H ENZYME DERIVED FROM HBV POLYMERASE, PROCESSES FOR PREPARATION AND USES FOR SCREENING ANTIVIRAL AGENTS THEREOF |
| 02/26/1998 | WO1998007865A1 Targeting adenovirus with use of constrained peptide motifs |
| 02/26/1998 | WO1998007864A1 Recombinant toxin fragments |
| 02/26/1998 | WO1998007859A2 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | WO1998007857A1 Reagents and methods useful for detecting diseases of the breast |
| 02/26/1998 | WO1998007855A2 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | WO1998007854A1 Human glycine transporter |
| 02/26/1998 | WO1998007840A1 Novel dnas and process for producing proteins by using the same |
| 02/26/1998 | WO1998007837A1 Improved nucleic acids for reducing carbohydrate epitopes |
| 02/26/1998 | WO1998007832A1 Recombinant vascular endothelial cell growth factor d (vegf-d) |
| 02/26/1998 | WO1998007817A1 Detergent compositions comprising antibody controlled lipolytic activity |
| 02/26/1998 | WO1998007754A1 T1 receptor-like ligand ii |
| 02/26/1998 | WO1998007737A1 Method for determining expression of aberrant forms of apc protein |
| 02/26/1998 | WO1998007444A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 02/26/1998 | WO1998003200A3 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease |
| 02/26/1998 | WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/26/1998 | WO1997046681A3 Galanin receptor galr2 |
| 02/26/1998 | WO1997029199A3 Prostate specific antigen peptides and uses thereof |
| 02/26/1998 | DE19732135A1 Gefrorenes Nahrungsmittelprodukt A frozen food product |
| 02/26/1998 | DE19649207C1 Nucleic acid characteristic of late or early passage cells immortalised by papilloma virus |
| 02/26/1998 | CA2264952A1 Improved nucleic acids for reducing carbohydrate epitopes |
| 02/26/1998 | CA2264200A1 Human endokine alpha |
| 02/26/1998 | CA2264192A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | CA2264054A1 Method for determining expression of aberrant forms of apc protein |
| 02/26/1998 | CA2263894A1 Novel human growth factors |
| 02/26/1998 | CA2263890A1 Recombinant vascular endothelial cell growth factor d (vegf-d) |
| 02/26/1998 | CA2263832A1 T1 receptor-like ligand ii |
| 02/26/1998 | CA2263830A1 T1 receptor-like ligand i |
| 02/26/1998 | CA2263192A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | CA2263189A1 A short-shafted adenoviral fiber and its use |
| 02/26/1998 | CA2263140A1 Targeting adenovirus with use of constrained peptide motifs |
| 02/26/1998 | CA2262515A1 Hbv polymerase, rnase h enzyme derived from hbv polymerase, processes for preparation and uses for screening antiviral agents thereof |
| 02/26/1998 | CA2235148A1 Novel dnas and process for producing proteins by using the same |
| 02/26/1998 | CA2232239A1 Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast |
| 02/25/1998 | EP0825259A1 Monoclonal antibody reactive with human-origin cetp and method of quantifying human-origin cetp |
| 02/25/1998 | EP0825256A2 Hybrid cell and its use for the preparation of a drug for the induction of tumourimmunity |
| 02/25/1998 | EP0825255A1 Method of producing activated killer monocytes |
| 02/25/1998 | EP0824594A1 Improved methods for transfecting t cells |
| 02/25/1998 | EP0824589A1 Utrophin gene promoter |
| 02/25/1998 | EP0824548A1 Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits |
| 02/25/1998 | EP0824546A2 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/25/1998 | EP0711304B1 Nickel-free hemoglobin and methods for producing such hemoglobin |
| 02/25/1998 | EP0690987A4 Immunoassay for determination of cells |
| 02/25/1998 | CN1174575A Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
| 02/25/1998 | CN1174574A DNA which regulates gene expression in coryne-form bacteria |
| 02/25/1998 | CN1174559A Major outer membrane protein CD of Moraxella |
| 02/25/1998 | CN1174558A Tumor necrosis factor-Gamma |
| 02/25/1998 | CN1174507A Antitumor agent potentiator comprising IL-6 antagonist |
| 02/24/1998 | US5721352 Entomopoxvirus expression system |
| 02/24/1998 | US5721349 Genetically altered mutant strain |
| 02/24/1998 | US5721348 DNA encoding PH-20 proteins |
| 02/24/1998 | US5721341 Derivatives of nucleosides, processes for the production of these derivatives of nucleosides and specific polyclonal and monoclonal antibodies of these derivatives |
| 02/24/1998 | US5721137 Stable synthetic promoter which controlls expression of a heterologous gene in escherichia and bacillus |
| 02/24/1998 | US5721130 Monitoring alzheimer's disease |
| 02/24/1998 | US5721122 Obtaining lymphocytes |
| 02/24/1998 | US5721114 Cultivating a transformed escherichia strain in culture medium, inducing expression of apolipoprotein a1-m protein of specific amino acid sequence in logarithmic growth phase before stationary phase is attained, separating the product |
| 02/24/1998 | US5721110 Reacting autoimmune antigen (from genetically engineered cells) with autoimmune antibody(from test sample) to form a complex which can be identified |
| 02/24/1998 | US5721108 Capable of mediating antibody-dependent cellular cytotoxicity or complement-dependent cytolysis |
| 02/24/1998 | US5721107 Antibodies to G protein coupled glutamate receptors |
| 02/24/1998 | US5721104 Screening assay for anti-HIV drugs |
| 02/24/1998 | US5720959 Malaria vaccine |
| 02/24/1998 | US5720954 Treating patient having carcinoma overexpressing her2 receptor by administering cytotoxic factor and antibody binding to receptor, which sensitizes tumor cells to said factor |
| 02/24/1998 | US5720952 Administering colony stimulating factor |
| 02/24/1998 | CA2002208C Extraction methods for preparing thromboplastin reagents |
| 02/24/1998 | CA1339681C Method for contraception by immunization against the zona pellucida |
| 02/19/1998 | WO1998006860A1 Peptide with inhibitory activity towards plant pathogenic fungi |
| 02/19/1998 | WO1998006849A1 Expression vectors, cells, and methods for preparing thrombopoietin polypeptides |
| 02/19/1998 | WO1998006848A1 GnRH-LEUKOTOXIN CHIMERAS |
| 02/19/1998 | WO1998006847A1 Human dbi/acbp-like protein |
| 02/19/1998 | WO1998006845A1 Mammalian ribonuclease inhibitors and use thereof |
| 02/19/1998 | WO1998006843A1 Neuritin, a neurogene |
| 02/19/1998 | WO1998006842A1 Mammalian cell surface antigens; related reagents |
| 02/19/1998 | WO1998006841A2 Two human nsp-like proteins |
| 02/19/1998 | WO1998006838A1 Methods and means for modifying complement activation |
| 02/19/1998 | WO1998006824A1 Immortalized cell lines for virus growth |
| 02/19/1998 | WO1998006822A1 Culture medium and use of the same |
| 02/19/1998 | WO1998006810A1 Detergent compositions comprising antibody controlled lipolytic activity |
| 02/19/1998 | WO1998006750A2 Resistance against nematodes and/or aphids |
| 02/19/1998 | WO1998006749A2 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 02/19/1998 | WO1998006748A1 Acquired resistance npr genes and uses thereof |
| 02/19/1998 | WO1998006737A1 Long wavelength engineered fluorescent proteins |
| 02/19/1998 | WO1998006736A1 Stable compositions for nucleic acid amplification and sequencing |
| 02/19/1998 | WO1998006734A1 Novel prokaryotic polynucleotides, polypeptides and their uses |